Outcome after surgical treatment of fragility ankle fractures in a certified orthogeriatric trauma center.

INTRODUCTION: Orthogeriatric ankle fractures seem to play an essential role in terms of quality of life in the elderly. Knowledge of the outcome after orthogeriatric ankle fractures is sparse. The present study investigates the outcome after surgically treated ankle fractures at a certified orthogeriatric trauma center. MATERIAL & METHODS: A retrospective observational study was performed investigating the outcome of surgically treated ankle fractures in orthogeriatric patients between 2015-2017. Outcome parameters included but were not limited to the EQ-5D 3 L, Barthel Index, Karlsson Score and the Charlson Comorbidity Index. Housing situation and mobility were evaluated and potential associations to the fracture pattern and the related treatment strategy were investigated. RESULTS: In total, 58 patients were included (age 77.7 ±â€¯6,2 years). The majority were AO-44 B2 fractures (72%). General outcome was related to the Parker score; a Parker Score of 9 prior surgery was independently associated with an improved outcome according to the EQ-5D 3 L and Barthel Index. Patients under 80 years of age also had better results. Place of residence did not significantly change after surgery. Neither different types of implants nor initial use of an external fixator (e.g. open fractures) did influence outcome. A wound healing impairment was found in 10% of our patients whereas the overall unplanned reoperation rate was 7%. Overall complication rate was 20%, one-year mortality was 10%. CONCLUSIONS: Surgically treated ankle fractures in the elderly which are treated in a certified geriatric fracture center seem to have limited negative effect on their quality of life. We did not observe the otherwise often demonstrated high mortality rates, but still nearly half of the patients demonstrated perioperative complications, which emphasizes the need for optimal perioperative care at an orthogeriatric trauma center. Since there was a reasonable number of patients with wound healing issues this study supports the idea of a staged protocol using external fixation with secondary ORIF.

Trochanteric fragility fractures : Treatment using the cement-augmented proximal femoral nail antirotation.

OBJECTIVE: Use of standardized cement augmentation of the proximal femur nail antirotation (PFNA) for the treatment of trochanteric fragility fractures, which are associated with high morbidity and mortality, to achieve safer conditions for immediate full weight-bearing and mobilization, thus, improving preservation of function and independency of orthogeriatric patients. INDICATIONS: Trochanteric fragility fractures (type 31-A1-3). CONTRAINDICATIONS: Ipsilateral arthritis of the hip, leakage of contrast agent into the hip joint, femoral neck fractures. SURGICAL TECHNIQUE: Reduction of the fracture on a fracture table if possible, or minimally invasive open reduction of the proximal femur, i. e., using collinear forceps if necessary. Positioning of guidewires for adjustment of the PFNA and the spiral blade, respectively. Exclusion of leakage of contrast agent and subsequent injection of TRAUMACEM™ V(+) into the femoral head-neck fragment via a trauma needle kit introduced into the spiral blade. Dynamic or static locking of the PFNA at the diaphyseal level. POSTOPERATIVE MANAGEMENT: Immediate mobilization of the patients with full weight-bearing and secondary prevention, such as osteoporosis management is necessary to avoid further fractures in the treatment of these patients. RESULTS: A total of 110 patients older than 65 years underwent the procedure. Of the 72 patients available for follow-up (average age 85.3 years), all fractures healed after an average of 15.3 months. No complications related with cement augmentation were observed. Approximately 60 % of patients achieved the mobility level prior to trauma.

Screening for colorectal cancer by faecal occult blood test: why people choose to refuse.

To better understand the personal barriers that limit participation in faecal occult blood test (FOBT) screening for colorectal cancer, non-participants from a recent screening initiative were sent detailed questionnaires, defining their reasons for not participating, as well as how to make screening more attractive. The important barrier was procrastination. The type of FOBT kit offered influenced the reasons for not participating. Convenient FOBT and greater general practitioner involvement may be important for optimizing community acceptance of FOBT-based screening.